Embryonic Stem Cell Research Oversight Committees
The National Academies called for the establishment of Embryonic Stem Cell Research Oversight (ESCRO) Committees in its 2005 "Guidelines for Human Embryonic Stem Cell Research" to manage the ethical and legal concerns in human embryonic stem cell research. Because of the complexity and novelty of many of the issues involved in that research, the Guidelines committee believes that all research institutions engaged in human embryonic stem cell research should create and maintain these committees at the local level.
Mike Castle
Castle cosponsored the Stem Cell Research Enhancement Act. The bill proposed expanding the number of embryonic stem cell lines that are eligible for federally funded research, expecting that this funding would generate more research and ultimately greater progress in developing new treatments for a wide range of medical conditions. Presently, the only embryonic stem cell lines eligible for federal funded research were derived before August 9, 2001. This legislation removes that date restriction, along with proposing stronger ethical requirements. After successfully passing both the U.S. Senate and the U.S. House, it received U.S. President George W. Bush's first presidential veto in July 2006.